Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
0.7655
+0.0035 (0.46%)
At close: Nov 21, 2025, 4:00 PM EST
0.7547
-0.0108 (-1.41%)
Pre-market: Nov 24, 2025, 4:27 AM EST
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $6.06 million as of November 24, 2025. Its market cap has decreased by -20.03% in one year.
Market Cap
6.06M
Enterprise Value
-4.19M
1-Year Change
-20.03%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $6.06M, an increase of 21.96%. That is a compound annual growth rate of 1.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 23, 2025 | 6.06M | -45.26% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | 67.08M | 364.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |